Discover why Johnson & Johnson is a top stock pick for income investors in 2025 with strong sales growth and promising ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB), a commercial-stage biopharmaceutical company with a "GOOD" InvestingPro Financial ...

Kennedy Jr. was pressed to clarify his views on vaccines, abortion and public health priorities in the first of two senate ...

Robert F. Kennedy Jr’s confirmation hearings began Wednesday before the Senate Finance Committee. He appears before the ...

We recently published a list of 12 Safe Stocks to Buy for the Long Term in 2025. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other safe stocks to ...

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

Robert F. Kennedy Jr. told the Senate Finance Committee that he is not anti-vaccine during his confirmation hearing for ...

Just a matter of days into the new Trump administration, LGBTQ+ issues have already been brought to the forefront.

After decades of a diversified healthcare business model, Johnson & Johnson has announced it plans to split off its consumer health division from its pharma and medical device operations.